Milrinone in enterovirus 71 brain stem encephalitis

研究成果: Short survey

7 引文 (Scopus)

摘要

Enterovirus 71 (EV71) was implicated in a widespread outbreak of hand-foot-and-mouth disease (HFMD) across the Asia Pacific area since 1997 and has also been reported sporadically in patients with brain stem encephalitis. Neurogenic shock with pulmonary edema (PE) is a fatal complication of EV71 infection. Among inotropic agents, milrinone is selected as a therapeutic agent for EV71- induced PE due to its immunopathogenesis. Milrinone is a type III phosphodiesterase inhibitor that has both inotropic and vasodilator effects. Its clinical efficacy has been shown by modulating inflammation, reducing sympathetic over-activity, and improving survival in patients with EV71-associated PE. Milrinone exhibits immunoregulatory and anti-inflammatory effects in the management of systemic inflammatory responses in severe EV71 infection.

原文English
文章編號82
期刊Frontiers in Pharmacology
7
發行號MAR
DOIs
出版狀態Published - 2016 三月 29

指紋

Milrinone
Enterovirus
Pulmonary Edema
Encephalitis
Enterovirus Infections
Brain Stem
Hand, Foot and Mouth Disease
Phosphodiesterase Inhibitors
Vasodilator Agents
Disease Outbreaks
Shock
Anti-Inflammatory Agents
Inflammation
Survival
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)

引用此文

@article{5838d4c1f46c435d85738d96bba6355e,
title = "Milrinone in enterovirus 71 brain stem encephalitis",
abstract = "Enterovirus 71 (EV71) was implicated in a widespread outbreak of hand-foot-and-mouth disease (HFMD) across the Asia Pacific area since 1997 and has also been reported sporadically in patients with brain stem encephalitis. Neurogenic shock with pulmonary edema (PE) is a fatal complication of EV71 infection. Among inotropic agents, milrinone is selected as a therapeutic agent for EV71- induced PE due to its immunopathogenesis. Milrinone is a type III phosphodiesterase inhibitor that has both inotropic and vasodilator effects. Its clinical efficacy has been shown by modulating inflammation, reducing sympathetic over-activity, and improving survival in patients with EV71-associated PE. Milrinone exhibits immunoregulatory and anti-inflammatory effects in the management of systemic inflammatory responses in severe EV71 infection.",
author = "Wang, {Shih Min}",
year = "2016",
month = "3",
day = "29",
doi = "10.3389/fphar.2016.00082",
language = "English",
volume = "7",
journal = "Frontiers in Pharmacology",
issn = "1663-9812",
publisher = "Frontiers Media S. A.",
number = "MAR",

}

Milrinone in enterovirus 71 brain stem encephalitis. / Wang, Shih Min.

於: Frontiers in Pharmacology, 卷 7, 編號 MAR, 82, 29.03.2016.

研究成果: Short survey

TY - JOUR

T1 - Milrinone in enterovirus 71 brain stem encephalitis

AU - Wang, Shih Min

PY - 2016/3/29

Y1 - 2016/3/29

N2 - Enterovirus 71 (EV71) was implicated in a widespread outbreak of hand-foot-and-mouth disease (HFMD) across the Asia Pacific area since 1997 and has also been reported sporadically in patients with brain stem encephalitis. Neurogenic shock with pulmonary edema (PE) is a fatal complication of EV71 infection. Among inotropic agents, milrinone is selected as a therapeutic agent for EV71- induced PE due to its immunopathogenesis. Milrinone is a type III phosphodiesterase inhibitor that has both inotropic and vasodilator effects. Its clinical efficacy has been shown by modulating inflammation, reducing sympathetic over-activity, and improving survival in patients with EV71-associated PE. Milrinone exhibits immunoregulatory and anti-inflammatory effects in the management of systemic inflammatory responses in severe EV71 infection.

AB - Enterovirus 71 (EV71) was implicated in a widespread outbreak of hand-foot-and-mouth disease (HFMD) across the Asia Pacific area since 1997 and has also been reported sporadically in patients with brain stem encephalitis. Neurogenic shock with pulmonary edema (PE) is a fatal complication of EV71 infection. Among inotropic agents, milrinone is selected as a therapeutic agent for EV71- induced PE due to its immunopathogenesis. Milrinone is a type III phosphodiesterase inhibitor that has both inotropic and vasodilator effects. Its clinical efficacy has been shown by modulating inflammation, reducing sympathetic over-activity, and improving survival in patients with EV71-associated PE. Milrinone exhibits immunoregulatory and anti-inflammatory effects in the management of systemic inflammatory responses in severe EV71 infection.

UR - http://www.scopus.com/inward/record.url?scp=84964636367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964636367&partnerID=8YFLogxK

U2 - 10.3389/fphar.2016.00082

DO - 10.3389/fphar.2016.00082

M3 - Short survey

AN - SCOPUS:84964636367

VL - 7

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

SN - 1663-9812

IS - MAR

M1 - 82

ER -